Hayden Panettiere's comments about Neutrogena dropping her after she revealed postpartum depression resurface following her death

Following the death of actress Hayden Panettiere, public attention has returned to a past controversy involving the skincare brand Neutrogena. Coverage from parade.com reports that a clip has resurfaced in which Panettiere discussed the brand dropping her as a partner after she spoke openly about her experience with postpartum depression (PPD). This resurgence of the story has led to widespread backlash against the company, with reports from Yahoo and NDTV indicating that the brand is currently facing calls for a boycott. The situation intensified shortly after her passing, bringing previous allegations of unfair treatment back into the public spotlight. Several major news outlets have tracked the resulting corporate response. According to reports from CBS News and The Daily Beast, Neutrogena has broken its silence to address its previous treatment of Panettiere.

Yahoo further specifies that the brand's response included the statement, ‘This isn't who we want to be,’ as the company attempted to manage the negative reception. The Cut has focused its analysis on unpacking the specific dynamics of the boycott, while NDTV highlighted the scale of the entity involved, describing Neutrogena as a billion-dollar skincare brand now grappling with significant reputational damage. The context driving this trend is rooted in the intersection of celebrity endorsement and mental health advocacy. Panettiere had previously gone public with her struggles with postpartum depression, a revelation that allegedly led to the termination of her professional relationship with Neutrogena. The current backlash emphasizes a public perception that the brand penalized the actress for disclosing a medical and mental health struggle. This historical conflict has regained momentum because of the emotional weight associated with the news of her death, transforming a past corporate dispute into a current social media movement.

Moving forward, the coverage suggests that the focus will remain on how Neutrogena handles the ongoing backlash. The brand has already begun addressing its history with Panettiere, but the extent of the boycott mentioned by Yahoo and NDTV remains a key point of observation. Observers are watching whether the company will provide further specifics regarding its past actions or if the public outcry will lead to broader changes in how the billion-dollar brand manages its partnerships regarding health and wellness disclosures. Current reports indicate the company is in a reactive posture as it addresses these resurfaced claims.